CONTENTS:
- Improving harm reduction services: A qualitative study on the perspectives of highly marginalized persons who inject drugs in Montreal. Poliquin H., Perreault M., Villela Guilhon A.C., Bertrand K., p. 375-401.
- Heads, seekers, psychonauts, and one-timers: Patterns in stories of psychedelic consumption. Brooks Dollar C., p. 402-421.
- COVID-19 vaccine uptake and attitudes within two cohorts of younger adult cannabis users. Fedorova E.V., Wong C.F., Conn B.M., Ataiants J., Lankenau S.E., p. 422-430.
- Benefits of continuing linkages to recovery homes following departure. Jason L.A., Menis N., p. 431-439.
- Recovery identity and psychosocial-spiritual health: A survey of individuals in remission from substance use disorders. Witte T., Amick M., Smith J., p. 440-450.
- Are illicit drugs a driving force for cryptomarket leadership? Hiramoto N., Tsuchiya Y., p. 451-474.
- Experiences administering naloxone among people in different social roles: People who use opioids and family members and friends. Urmanche A.A., Harocopos A., p. 475-489.
- Pandemic procedures: Adapting problem-solving court (PSC) operations and treatment protocols during COVID-19. Smith L.R., Farago F., Witte J.C., Blue T., Gordon M.S., Taxman F.S., p. 490-498.
- "I had no problems and just felt so fabulous": The “storylines” of methamphetamine initiation in Aotearoa/New Zealand. Bax T., p. 499-516.